Private hospital operator Mediclinic, recently delisted from the JSE by a Remgro-led consortium, has opted not to pay a final dividend for the year to end-March to prevent reducing the multibillion-rand acquisition price paid by the consortium.

“The group’s dividend policy before the acquisition was to target a payout ratio of between 25% and 35% of full-year adjusted earnings. Mediclinic’s board may revise the policy at its discretion,” Remgro said on Thursday...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.